NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)

Trial Profile

NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs CLR 1404 I-124 (Primary) ; CLR 1404 I-131 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Diagnostic use; Pharmacodynamics
  • Most Recent Events

    • 18 Sep 2015 Study design is changed from Interventional to observational also number of treatment arms changed from 2 to 1 as reported by ClinicalTrials.gov record.
    • 18 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported byClinicalTrials.gov record.
    • 07 May 2015 Planned number of patients changed from 27 to 31 as per ClinicalTrials.gov record..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top